Find a ROS1 Physician

ROS1 Clinician-Researchers

ROS1+ cancer is not a common cancer, and treatment options are evolving quickly.  Many physicians may find they are not familiar with the most current treatment options.  If a patient or a physician has questions about the next step in treating ROS1+ cancer, they might want to consult one of the physicians listed here.  All have treated ROS1+ cancer patients. In addition, they have :

  • participated in research on ROS1+ cancer (ROS1 Clinician-Researchers), or

  • consulted with ROS1 Clinician-Researchers about treating ROS1+ cancer patients (ROS1 Clinicians). 

 

ROS1 Clinician-Researchers have participated in ROS1 research and will have the most current information about ROS1+ cancer treatment options, acquired resistance, and clinical trials.  Patients who are seeking to learn the best evidence-based options for treatment of their ROS1+ cancer can arrange for an in-person second opinion with these physicians; we've indicated those who also offer remote second opinions to patients.  Physicians who need more information about best practices in treating ROS1+ cancer can contact these physicians by email to arrange for a peer consult. 

Camidge_edited_edited.jpg

University of Colorado
Denver, Colorado USA

Remote second opinion available

csm_218_1629259379_368a283932_edited_edited.jpg

Massachusetts General Hospital
Boston, Massachusetts, USA

286_edited_edited.jpg

Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, Massachusetts, USA

Photo_B_edited_edited.jpg

Gustave Roussy,
Grand-Paris, France

Remote second opinion available

drilon-alexander_210210_020-1200x800_edited_edited.jpg

Memorial Sloan Kettering Cancer Center
New York City, New York, USA

csm_1457_1642309222_5871d0beb8.jpg

Massachusetts General Hospital
Boston, Massachusetts, USA

Christine Lovly_Headshot_1_for Web_edited.jpg

Vanderbilt Ingram Cancer Center, Nashville, TN 

ou sai hong 160 jpg_edited.jpg

University of California
Irvine, California, USA

Tejas Patil_edited.jpg

University of Colorado
Denver, Colorado USA

Remote second opinion available

riely-gregory_edited_edited.jpg

Memorial Sloan Kettering Cancer Center New York City, New York, USA

ravi-salgia_edited.jpg

City of Hope
Duarte, California, USA

van der Wekken_edited.jpg

University Medical Centre Groningen
Groningen, Netherlands

geoffrey_shapiro_pf_geoffrey_shapiro_sog_9680_10.jpg

Dana-Farber Cancer Institute
Boston, Massachusetts, USA

picture-1087-1466125695_edited_edited.jpg

Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia

Jurgen Wolf_edited_edited_edited.jpg

University Hospital of Cologne,
Center for Integrated Oncology Köln Bonn
Köln, Germany

Lyudmila  Bazhenova_edited.jpg

Moores Cancer Center at
University of California San Diego
San Diego, CA, USA

Natasha Leighl _edited_edited_edited.jpg

 Princess Margaret Cancer Centre/
University Health Network
Toronto, Canada

Viteri_edited_edited.jpg

La Unidad de Oncología de Clínicas Mi (UOMI) Cancer Center
Barcelona, Spain

Antonio Calles_edited.jpg

Hospital General Universitario Gregorio Marañón
Madrid, Spain

Sanjay Popat_edited_edited.jpg

 The Royal Marsden NHS Foundation Trust
London, United Kingdom

 

ROS1 Clinicians

ROS1 Clinicians have treated patients who have ROS1+ cancer AND have consulted a ROS1 Clinician-Researcher regarding treatment options for one or more patients.  

Virginia Mason Medical Center
Seattle, WA, USA

Fred Hutchinson Cancer Center
Seattle, WA  USA

 

Know a physician who treats ROS1+ cancer?
Please tell us about them using this survey:
https://www.surveymonkey.com/r/SuggestaROS1Physician